A team of researchers from Mahidol University of Thailand and Osaka University said Wednesday they have developed antibodies that could lead to the treatment of dengue fever.
A patent application for anti-dengue virus human monoclonal antibodies has been filed in Japan, the team said. Their research has drawn the attention of an Indian pharmaceutical company that may be interested in developing commercial products to treat the incurable mosquito-borne tropical disease, it said.
Around 180 varieties of the antibodies were collected from dengue fever patients and three showed strong reactions to four types of the virus, Osaka University professor Kazuyoshi Ikuta said.